Completed OBSERVATIONAL NCT05605236

Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0) (Stereotactic)

Sponsor: University Hospital, Strasbourg, France

Updated 4 times since 2022 Last updated: Dec 13, 2023 Started: Feb 16, 2020 Primary completion: May 16, 2022 Completion: Jul 16, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Bronchial Cancer and is currently completed. University Hospital, Strasbourg, France leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2024 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Dec 2022 — Jan 2024 [monthly]

Recruiting

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Strasbourg, France

Data source: University Hospital, Strasbourg, France

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Strasbourg, France